Medication info
Irbel Tablet (Irbesartan)

Irbel Tablet (Irbesartan)

Prescription medicationTabletOral
Ingredient · strength
Irbesartan›150mg / 1 tablet
Manufacturer / importer
Kips Biopharma Co., Ltd.
Appearance
White or almost white, convex oval tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200703851 · Notified 2007.04.04 · Insurance code 693200340

Summary

Main use
Treatment of essential hypertension and diabetic nephropathy in patients with type 2 diabetes mellitus accompanied by hypertension
Who takes it
Adults
Adult dose
This medicine may be taken with or without food. 1. Essential hypertension Adults: Administer irbesartan orally at a dose of 150 mg once daily. If the effect is insufficient, the dose may be increased to 300 mg. In general, blood pressure control over 24 hours is better with 150 mg once daily than with 75 mg once daily; however, 75 mg may be considered in special circumstances (e.g., at the start of treatment, in patients receiving hemodialysis, or in patients aged 75 years or older). If blood pressure is not adequately controlled with monotherapy, another antihypertensive agent may be coadministered. The effect is increased particularly when coadministered with a low-dose diuretic (e.g., hydrochlorothiazide). 2. Nephropathy in patients with type 2 diabetes and hypertension Adults: It is recommended to start oral administration of this medicine at 150 mg once daily and increase the dose to 300 mg for maintenance. If necessary, another antihypertensive agent may be coadministered to achieve the target blood pressure. ○ Older adults Dose adjustment is generally not necessary; however, a starting dose of 75 mg should be considered in patients aged 75 years or older. ○ Patients with renal impairment Dose adjustment is generally not necessary; however, a starting dose of 75 mg should be considered in patients receiving hemodialysis. ○ Patients with hepatic impairment Although no specific dose adjustment is generally necessary in patients with mild to moderate hepatic impairment, it is recommended that the dose not exceed 150 mg daily. There is no clinical experience in patients with severe hepatic impairment.

Ingredients

Manufacturer
Kips Biopharma Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and diabetic nephropathy in patients with type 2 diabetes mellitus accompanied by hypertension

  • Essential hypertension
  • hypertension
  • kidney disease in patients with type 2 diabetes
View approved original text

This medication helps control blood pressure in patients with essential hypertension, and it is used for the prevention and treatment of kidney disease that may occur in patients with hypertension and type 2 diabetes.

How to take

Adult dose

This medicine may be taken with or without food. 1. Essential hypertension Adults: Administer irbesartan orally at a dose of 150 mg once daily. If the effect is insufficient, the dose may be increased to 300 mg. In general, blood pressure control over 24 hours is better with 150 mg once daily than with 75 mg once daily; however, 75 mg may be considered in special circumstances (e.g., at the start of treatment, in patients receiving hemodialysis, or in patients aged 75 years or older). If blood pressure is not adequately controlled with monotherapy, another antihypertensive agent may be coadministered. The effect is increased particularly when coadministered with a low-dose diuretic (e.g., hydrochlorothiazide). 2. Nephropathy in patients with type 2 diabetes and hypertension Adults: It is recommended to start oral administration of this medicine at 150 mg once daily and increase the dose to 300 mg for maintenance. If necessary, another antihypertensive agent may be coadministered to achieve the target blood pressure. ○ Older adults Dose adjustment is generally not necessary; however, a starting dose of 75 mg should be considered in patients aged 75 years or older. ○ Patients with renal impairment Dose adjustment is generally not necessary; however, a starting dose of 75 mg should be considered in patients receiving hemodialysis. ○ Patients with hepatic impairment Although no specific dose adjustment is generally necessary in patients with mild to moderate hepatic impairment, it is recommended that the dose not exceed 150 mg daily. There is no clinical experience in patients with severe hepatic impairment.

Precautions

This medication may cause serious harm to the fetus or newborn, especially during pregnancy, so it should be discontinued immediately if pregnancy is confirmed. It should not be used in individuals with hypersensitivity to this drug, or in pregnant or breastfeeding women, severe liver impairment patients, or patients with specific hereditary diseases. Caution is advised for elderly patients or those with hyperkalemia, liver impairment, or heart disease, and blood pressure, kidney function, and electrolyte levels should be monitored regularly. Mild side effects such as dizziness, fatigue, headache, cough, and indigestion may occur during treatment, but they are mostly transient. Rarely, severe side effects may occur, such as angioedema, hyperkalemia, shock, renal failure, liver dysfunction, hypoglycemia, and myalgia, so if any unusual symptoms occur, medical advice should be sought immediately. This drug may interact with other antihypertensives, diuretics, potassium preparations, lithium, and nonsteroidal anti-inflammatory drugs (NSAIDs), so it is essential to inform about any concurrent medications. Women who are pregnant or planning to become pregnant should not take this medication, and nursing mothers are also advised to avoid it. The safety and efficacy in children have not been established, so it should not be used in pediatric patients. Elderly patients may be at risk of stroke and other complications due to blood pressure lowering, so treatment should start at a low dose and their condition should be carefully monitored. In cases of overdose, symptoms such as hypotension and tachycardia may occur, and appropriate treatment and monitoring should be provided according to the symptoms. Store out of reach of children, and do not transfer to other containers.

Side effects

  • Respiratory infection
  • headache
  • musculoskeletal pain
  • dizziness
  • fatigue
  • diarrhea
  • cough
  • nausea
  • vomiting
  • musculoskeletal trauma
Show 108 more
  • chest pain
  • indigestion
  • heartburn
  • edema
  • abdominal pain
  • rash
  • tachycardia
  • anxiety
  • irritability
  • upper urinary tract infection
  • fever
  • chills
  • facial edema
  • arm edema
  • flushing
  • hypertension
  • heart murmur
  • myocardial infarction
  • angina
  • arrhythmia
  • conduction abnormality
  • cardiac-respiratory arrest
  • heart failure
  • hypertensive crisis
  • itching
  • dermatitis
  • petechiae
  • erythema
  • hives
  • sexual dysfunction
  • changes in sexual function
  • gout
  • constipation
  • oral lesions
  • gastroenteritis
  • abdominal distension
  • limb edema
  • muscle spasm
  • arthritis
  • myalgia
  • joint stiffness
  • bursitis
  • muscle weakness
  • sleep disorders
  • paralysis
  • somnolence
  • mood disorders
  • depression
  • sensory abnormalities
  • tremor
  • transient ischemia
  • cerebrovascular accident
  • abnormal urination
  • prostate abnormalities
  • epistaxis
  • bronchitis
  • congestion
  • pulmonary congestion
  • dyspnea
  • wheezing
  • visual impairment
  • auditory abnormalities
  • otitis
  • ear pain
  • conjunctivitis
  • eyelid abnormalities
  • ear abnormalities
  • dizziness
  • orthostatic dizziness
  • orthostatic hypotension
  • increased plasma creatine kinase
  • hyperkalemia
  • hypersensitivity reactions
  • rash
  • hives
  • angioedema
  • anaphylactic shock
  • anaphylactic reaction
  • weakness
  • diarrhea
  • indigestion
  • nausea
  • tinnitus
  • myalgia
  • increased plasma creatine kinase
  • arthralgia
  • hepatitis
  • hepatic dysfunction
  • renal failure
  • psoriasis
  • photosensitivity reaction
  • anemia
  • thrombocytopenia
  • hypoglycemia
  • angioedema
  • shock
  • syncope
  • loss of consciousness
  • renal failure
  • liver dysfunction
  • jaundice
  • rhabdomyolysis
  • weakness
  • elevated creatine kinase
  • increased serum and urinary myoglobin
  • hypotension
  • tachycardia
  • bradycardia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent exposure to air or moisture. It is also advisable to store it in a cool, dry place below 30 degrees Celsius.

Appearance and packaging

Appearance

White or almost white, convex oval tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.